542678.BO Stock Analysis
54
Uncovered
Cian Healthcare Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Cian Healthcare Ltd. engages in the development and manufacture of pharmaceuticals, cosmeceuticals, and nutraceutical products. The company is headquartered in Pune, Maharashtra. The company went IPO on 2019-05-23. The firm is engaged in the manufacturing and marketing of pharmaceutical products. The company renders services for Third Party Pharmaceutical Manufacturing. The firm is engaged in manufacturing multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, and cosmetics. Its portfolio comprises of gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, and vitamins and nutrient products. The firm also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, and Sri Lanka. The company is also engaged in the business of manufacturing cosmetic products. The firm caters to approximately eight segments of the pharma industry (branches of medicines), including 500 brands across 11 product lines. The firm's subsidiary includes Dr. Smith Biotech Private Limited.